Phase 2 Heart Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with long-term heart failure caused by reduced blood flow to the heart, and who are scheduled to have open-heart bypass surgery (a procedure to reroute blood around blocked arteries)
- People whose heart pumping strength, measured by a heart ultrasound at the initial screening appointment, is below 40% (this measurement is called ejection fraction, and a lower number means the heart is not pumping as strongly as normal)
- There may be additional criteria not listed here (confirm with trial site)
Who may not be able to join:
- People who also have serious problems with their heart valves
- People who experienced a sudden, severe heart event (such as a heart attack) within the 3 months before agreeing to join the trial
- There may be additional exclusion criteria not listed here (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Shigeru Miyagawa, profesor, Osaka University
Phone: 81-3-6832-6014
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Time to the first occurrence of the cardiovascular events
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.